Oral anticoagulant treatment and risk of kidney disease-a nationwide, population-based cohort study.

"CONFLICT OF INTEREST STATEMENT The Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, is involved in studies with funding from various companies as research grants to (and administered by) Aarhus University. None of these studies is related to the current study. J.-J.C. acknowledges consultancy for AstraZeneca and Baxter, and grant support to Karolinska Institutet from AstraZeneca, Viforpharma and Astellas, all outside the submitted work. H.B. acknowledges research grant or contracts (paid to institution) from Vifor Pharma and GSK; consulting and/or advisory board fees from AstraZeneca, Vifor Pharma, Boehringer Ingelheim and GSK; payment or honoraria for manuscripts, lectures, presentations or chair at meetings from AstraZeneca, Alexion, NOVO, Netdoktor.dk; support for meetings and/or travel from AstraZeneca, expert testimony/working groups within the Danish Society of Nephrology and Danish Board of Health; and chair of the Danish Society of Nephrology. K.A. was employed at Aarhus University Hospital during the preparation of this work, but is now an employee of Novo Nordisk A/S."

"FUNDING This study was partly funded by the Independent Research Fund Denmark (grant number 1057-00037B). C.F.C. acknowledges support from the Independent Research Fund Denmark (grant number 0134-00407B). J.-J.C. acknowledges support from the Swedish Research Council (#2019-01059) and the Swedish Heart and Lung Foundation. A.E.F.V. undertook a research stay at Karolinska Institutet to complete this study with support from Foundation of 1870, William Demant Foundation, The Family Hede Nielsen Foundation, Master carpenter S. Jacobsen's Foundation and Dagmar Marshall's Foundation."

"The study was reported to the Danish Data Protection Agency through registration at Aarhus University (record number: 2016-051-000001/812). According to Danish legislation, approval from an ethics committee or informed consent from patients is not required for registry-based studies."